Cargando…

Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system

OBJECTIVE: To evaluate the impact of the meningococcal A (MenA) vaccine introduction in Mali through mass campaigns on the routine immunization program and the wider health system. METHODS: We used a mixed-methods case-study design, combining semi-structured interviews with 31 key informants, a surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Mounier-Jack, Sandra, Burchett, Helen Elizabeth Denise, Griffiths, Ulla Kou, Konate, Mamadou, Diarra, Kassibo Sira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Health: Science and Practice 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168598/
https://www.ncbi.nlm.nih.gov/pubmed/25276567
http://dx.doi.org/10.9745/GHSP-D-13-00130
_version_ 1782335577552584704
author Mounier-Jack, Sandra
Burchett, Helen Elizabeth Denise
Griffiths, Ulla Kou
Konate, Mamadou
Diarra, Kassibo Sira
author_facet Mounier-Jack, Sandra
Burchett, Helen Elizabeth Denise
Griffiths, Ulla Kou
Konate, Mamadou
Diarra, Kassibo Sira
author_sort Mounier-Jack, Sandra
collection PubMed
description OBJECTIVE: To evaluate the impact of the meningococcal A (MenA) vaccine introduction in Mali through mass campaigns on the routine immunization program and the wider health system. METHODS: We used a mixed-methods case-study design, combining semi-structured interviews with 31 key informants, a survey among 18 health facilities, and analysis of routine health facility data on number of routine vaccinations and antenatal consultations before, during, and after the MenA vaccine campaign in December 2010. Survey and interview data were collected at the national level and in 2 regions in July and August 2011, with additional interviews in January 2012. FINDINGS: Many health system functions were not affected—either positively or negatively—by the MenA vaccine introduction. The majority of effects were felt on the immunization program. Benefits included strengthened communication and social mobilization, surveillance, and provider skills. Drawbacks included the interruption of routine vaccination services in the majority of health facilities surveyed (67%). The average daily number of children receiving routine vaccinations was 79% to 87% lower during the 10-day campaign period than during other periods of the month. Antenatal care consultations were also reduced during the campaign period by 10% to 15%. Key informants argued that, with an average of 14 campaigns per year, mass campaigns would have a substantial cumulative negative effect on routine health services. Many also argued that the MenA campaign missed potential opportunities for health systems strengthening because integration with other health services was lacking. CONCLUSION: The MenA vaccine introduction interrupted routine vaccination and other health services. When introducing a new vaccine through a campaign, coverage of routine health services should be monitored alongside campaign vaccine coverage to highlight where and how long services are disrupted and to mitigate risks to routine services.
format Online
Article
Text
id pubmed-4168598
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Global Health: Science and Practice
record_format MEDLINE/PubMed
spelling pubmed-41685982014-09-30 Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system Mounier-Jack, Sandra Burchett, Helen Elizabeth Denise Griffiths, Ulla Kou Konate, Mamadou Diarra, Kassibo Sira Glob Health Sci Pract Original Articles OBJECTIVE: To evaluate the impact of the meningococcal A (MenA) vaccine introduction in Mali through mass campaigns on the routine immunization program and the wider health system. METHODS: We used a mixed-methods case-study design, combining semi-structured interviews with 31 key informants, a survey among 18 health facilities, and analysis of routine health facility data on number of routine vaccinations and antenatal consultations before, during, and after the MenA vaccine campaign in December 2010. Survey and interview data were collected at the national level and in 2 regions in July and August 2011, with additional interviews in January 2012. FINDINGS: Many health system functions were not affected—either positively or negatively—by the MenA vaccine introduction. The majority of effects were felt on the immunization program. Benefits included strengthened communication and social mobilization, surveillance, and provider skills. Drawbacks included the interruption of routine vaccination services in the majority of health facilities surveyed (67%). The average daily number of children receiving routine vaccinations was 79% to 87% lower during the 10-day campaign period than during other periods of the month. Antenatal care consultations were also reduced during the campaign period by 10% to 15%. Key informants argued that, with an average of 14 campaigns per year, mass campaigns would have a substantial cumulative negative effect on routine health services. Many also argued that the MenA campaign missed potential opportunities for health systems strengthening because integration with other health services was lacking. CONCLUSION: The MenA vaccine introduction interrupted routine vaccination and other health services. When introducing a new vaccine through a campaign, coverage of routine health services should be monitored alongside campaign vaccine coverage to highlight where and how long services are disrupted and to mitigate risks to routine services. Global Health: Science and Practice 2014-01-15 /pmc/articles/PMC4168598/ /pubmed/25276567 http://dx.doi.org/10.9745/GHSP-D-13-00130 Text en © Mounier-Jack et al. http://creativecommons.org/licenses/by/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
spellingShingle Original Articles
Mounier-Jack, Sandra
Burchett, Helen Elizabeth Denise
Griffiths, Ulla Kou
Konate, Mamadou
Diarra, Kassibo Sira
Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system
title Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system
title_full Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system
title_fullStr Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system
title_full_unstemmed Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system
title_short Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system
title_sort meningococcal vaccine introduction in mali through mass campaigns and its impact on the health system
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168598/
https://www.ncbi.nlm.nih.gov/pubmed/25276567
http://dx.doi.org/10.9745/GHSP-D-13-00130
work_keys_str_mv AT mounierjacksandra meningococcalvaccineintroductioninmalithroughmasscampaignsanditsimpactonthehealthsystem
AT burchetthelenelizabethdenise meningococcalvaccineintroductioninmalithroughmasscampaignsanditsimpactonthehealthsystem
AT griffithsullakou meningococcalvaccineintroductioninmalithroughmasscampaignsanditsimpactonthehealthsystem
AT konatemamadou meningococcalvaccineintroductioninmalithroughmasscampaignsanditsimpactonthehealthsystem
AT diarrakassibosira meningococcalvaccineintroductioninmalithroughmasscampaignsanditsimpactonthehealthsystem